Verrica Pharmaceuticals Files 8-K

Ticker: VRCA · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1660334

Verrica Pharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyVerrica Pharmaceuticals Inc. (VRCA)
Form Type8-K
Filed DateJul 1, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing-update

Related Tickers: VERR

TL;DR

VERR filed an 8-K on 6/27/25 - looks like a material agreement.

AI Summary

On June 27, 2025, Verrica Pharmaceuticals Inc. entered into a material definitive agreement. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Delaware and its principal executive offices are located in West Chester, PA.

Why It Matters

This 8-K filing indicates a significant event for Verrica Pharmaceuticals, potentially related to a new agreement or financial update, which could impact its stock.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of specific details in this summary requires further investigation.

Key Players & Entities

  • Verrica Pharmaceuticals Inc. (company) — Registrant
  • June 27, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • West Chester, PA (location) — Address of Principal Executive Offices
  • 484-453-3300 (phone_number) — Registrant's telephone number

FAQ

What is the nature of the material definitive agreement entered into by Verrica Pharmaceuticals?

The filing does not specify the details of the material definitive agreement, only that one was entered into on June 27, 2025.

What other items are included in this 8-K filing?

This 8-K filing also includes Regulation FD Disclosure and Financial Statements and Exhibits.

When was Verrica Pharmaceuticals Inc. incorporated?

Verrica Pharmaceuticals Inc. is incorporated in Delaware.

Where are Verrica Pharmaceuticals Inc.'s principal executive offices located?

Verrica Pharmaceuticals Inc.'s principal executive offices are located at 44 West Gay Street, Suite 400, West Chester, PA 19380.

What is the company's telephone number?

The company's telephone number, including area code, is (484) 453-3300.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Verrica Pharmaceuticals Inc. (VRCA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.